Introduction Even in transplant-eligible (TE) patients, typical first-line treatments for high-risk (HR) newly-diagnosed multiple myeloma (NDMM) have dismal outcomes. A high-efficacy, safe CAR-T treatment could address this large..
Gomarara reropa imhando yegomarara rinobata zvose ropa nemwongo. Imhando yechishanu yakajairika yegomarara pasi rose, iine vanhu vanosvika miriyoni 1.24 varwere vanoonekwa gore rega rega. Kufunga kuti gomarara reropa rinorapika here? Fin..
Huwandu hwekupindura kweiyi shanduko yekurapa cancer inonzi FUCASO ndeye 96%. Mvumo yeNMPA inoratidza shanduko mukurwisa kweChina kurwisa multiple myeloma. Iyi blog inoongorora kushanda kwekurapa uku, s..
Free cancer treatment in China is providing hope and healing to people in need. So, if you are unable to opt for cancer treatment because of its extensive cost, this guide is specially meant for you. Find out how reputed organiz..
Read our guide to learn about the silent indicators of multiple myeloma. Learn to spot them early, so you can make smart choices for your health. Don't ignore the warning signs, empower yourself with knowledge and take charge..
Learn about the different stages and types of multiple myeloma. Find hope and support with information on treatments and coping strategies. This simple guide can help you take charge of your health and fight against multiple myel..
Unoda kuziva kuti nzira yekurapa iri kuponesa sei hupenyu hwevarwere vakawanda vemyeloma? Verenga blog yedu kuti udzidze zvakawanda nezve iyi nzira yekuponesa hupenyu! Ngativhure peji regomarara pamwe chete. Nyaya yako yetariro inotangira pano. Hell..
Nov 2023: Elranatamab-bcmm (Elrexfio, Pfizer, Inc.) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that was given accelerated approval by the Food and Drug Administration for adults with relapsed or ..
Nyamavhuvhu 2023: Talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) yakapihwa mvumo yekukurumidzira neFood and Drug Administration yekurapwa kwevakuru vane kudzokazve kana kuramba akawanda myeloma avo vakamboitika pa.
Brief Summary: A study of APRIL CAR-T cells therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma Detailed Description: This is a single arm, open-label, single-center stu..